reported that taurine improves obesity and diabetes by restoring the rhythmic expression of PER1 in pancreatic β-cells, suggesting that PER1 may serve as a potential target for taurine-based therapies in obesity and diabetes (77). The gene discussed is PER1; the disease is obesity due to melanocortin 4 receptor deficiency.